MiMedx Group Inc. (MDXG)
NASDAQ: MDXG
· Real-Time Price · USD
6.38
-0.05 (-0.78%)
At close: Jun 02, 2025, 3:59 PM
6.31
-1.17%
After-hours: Jun 02, 2025, 04:09 PM EDT
MiMedx Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Surgical Revenue | 117.88M |
| Surgical Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 59.97M | 61.04M | 53.52M | 55.4M | 55.13M | 54.35M | 52.57M | 51.92M | 52.28M | 49.95M | 53.48M | 55.79M | 49.57M | 53.07M | 46.29M | 53.6M | 45.4M | 48.71M | 48.05M | 37.33M | 46.94M | 45.44M | 51.26M | 50.64M | 50.86M | 66.3M | 58.74M | 67.58M | 65.91M | 51.62M | 60.23M | 55.31M | 52.95M | 48.4M | 48.18M | 42.77M | 40.65M | 36.52M | 34.9M | 32.65M | 29.31M |
| Selling, General, and Administrative Revenue Growth | -1.76% | +14.06% | -3.40% | +0.49% | +1.43% | +3.39% | +1.24% | -0.68% | +4.67% | -6.60% | -4.15% | +12.55% | -6.59% | +14.64% | -13.64% | +18.05% | -6.78% | +1.37% | +28.71% | -20.48% | +3.30% | -11.34% | +1.22% | -0.43% | -23.28% | +12.86% | -13.08% | +2.54% | +27.68% | -14.30% | +8.89% | +4.46% | +9.41% | +0.45% | +12.64% | +5.23% | +11.29% | +4.65% | +6.89% | +11.41% | n/a |
| Research and Development Revenue | 3.33M | 3.57M | 2.92M | 3.01M | 2.84M | -5.5M | 3.17M | 8.5M | 6.5M | 5.4M | 5.95M | 5.51M | 5.96M | 4.58M | 4.37M | 4.06M | 4.34M | 3.44M | 3.37M | 2.26M | 2.65M | 2.72M | 2.69M | 2.83M | 2.9M | 4.54M | 3.96M | 3.72M | 3.54M | 3.47M | 5.48M | 4.75M | 4.2M | 3.46M | 2.92M | 3.17M | 2.5M | 2.34M | 2.19M | 2.05M | 1.83M |
| Research and Development Revenue Growth | -6.80% | +22.38% | -3.12% | +6.02% | -151.63% | -273.32% | -62.63% | +30.80% | +20.30% | -9.29% | +8.00% | -7.58% | +30.36% | +4.74% | +7.51% | -6.36% | +26.32% | +1.87% | +49.27% | -14.75% | -2.54% | +1.04% | -4.84% | -2.55% | -36.08% | +14.59% | +6.53% | +4.91% | +2.16% | -36.69% | +15.46% | +12.97% | +21.59% | +18.40% | -7.86% | +26.92% | +6.62% | +7.04% | +6.48% | +12.18% | n/a |